| EARNINGS PER SHARE |
EARNINGS PER SHARE | | | | | | | | | | | | | | | | | | | | | | | | | Table 17.1: Details of Basic and Dilutive Loss Per Share | | For the Three Months Ended June 30, | | For the Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Basic net loss per share: | | | | | | | | | Numerator | | | | | | | | | Net loss including non-controlling interests | $ | (4,039,567) | | | $ | (5,290,414) | | | $ | (6,601,353) | | | $ | (15,538,900) | | | Less: Net loss attributable to non-controlling interest | (283,793) | | | (101,659) | | | (717,117) | | | (101,659) | | | Net loss attributable to common stockholders - basic | (3,755,774) | | | (5,188,755) | | | (5,884,236) | | | (15,437,241) | | | Denominator | | | | | | | | | Weighted average shares outstanding - basic | 9,065,675 | | | 1,204,462 | | | 6,826,267 | | | 932,849 | | | Basic net loss per share attributable to common stockholders | $ | (0.41) | | | $ | (4.31) | | | $ | (0.86) | | | $ | (16.55) | | | Diluted net loss per share: | | | | | | | | | Numerator | | | | | | | | | Net loss attributable to common stockholders - basic | $ | (3,755,774) | | | $ | (5,188,755) | | | $ | (5,884,236) | | | $ | (15,437,241) | | | Add: Interest for subordinated convertible promissory note | - | | | 2,500 | | | - | | | 38,333 | | | Net loss attributable to common stockholders - diluted | $ | (3,755,774) | | | $ | (5,186,255) | | | $ | (5,884,236) | | | $ | (15,398,908) | | | Denominator | | | | | | | | | Weighted average shares outstanding - basic | 9,065,675 | | | 1,204,462 | | | 6,826,267 | | | 932,849 | | | Weighted-average effect of potentially dilutive securities: | | | | | | | | | Conversion of subordinated convertible promissory note | - | | | 57,884 | | | - | | | 3,360 | | | Conversion of Series A Convertible Preferred Stock | - | | | 70,203 | | | - | | | - | | | Conversion of Series B Convertible Preferred Stock | - | | | 200,000 | | | - | | | - | | | Weighted average shares outstanding - diluted | 9,065,675 | | | 1,532,549 | | | 6,826,267 | | | 936,209 | | | Dilutive net loss per share attributable to common stockholders | $ | (0.41) | | | $ | (3.38) | | | $ | (0.86) | | | $ | (16.45) | |
| | | | | | | | | | | | | | | | | | | | | | | | | Table 17.2: Details of Potentially Dilutive Effect of Securities Excluded from Dilutive EPS due to Anti-Dilutive Effect | | For the Three Months Ended June 30, | | For the Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Conversion of Series A Convertible Preferred Stock | - | | 152,335 | | - | | 115,303 | | Conversion of Series B Convertible Preferred Stock | 1,347 | | 45 | | 1,347 | | 57,054 | | Conversion of Series C Convertible Preferred Stock | 18,925 | | 1,212 | | 21,501 | | 1,212 | | Conversion of Series D Convertible Preferred Stock | 150,000 | | 5,040 | | 150,000 | | 15,386 | | Conversion of Series E Convertible Preferred Stock | 51 | | 2 | | 51 | | 1 | | Conversion of Series G Convertible Preferred Stock | 686,270 | | - | | 686,270 | | - | | Conversion of Series H Convertible Preferred Stock | 431,982 | | - | | 217,184 | | - | | Conversion of Series I Convertible Preferred Stock | 121,557,333 | | - | | 61,114,460 | | - | | Exercise of investor and placement agent warrants | 5,623,687 | | 618,161 | | 5,623,687 | | 495,585 |
|